论文部分内容阅读
老年性黄斑变性是一种严重威胁老年人视功能的眼底病变,在西方国家已成为第一位的致盲性眼病,在亚洲的发病率亦呈逐渐增多的趋势。本文针对治疗湿性老年性黄斑变性的治疗方法之一,利用药物维替泊芬进行的光动力疗法,进行药物经济学分析。本文采用成本-效益分析法,从而能够使读者直观地看到该疗法相关的成本与收益,并对无法货币化的患者生命质量进行量化,以期能够为读者提供相关信息。
Age-related macular degeneration is a retinal lesions that seriously threaten the visual function of the elderly. It has become the first blinding eye disease in western countries, and the incidence in Asia is gradually increasing. In this paper, for the treatment of wet age-related macular degeneration, one of the treatment methods, the use of the drug verteporfin photodynamic therapy for drug economics analysis. This article uses cost-benefit analysis to enable readers to visualize the costs and benefits associated with the therapy and to quantify the quality of life of patients who can not monetize themselves, in the hope of providing readers with relevant information.